Mirabella, Massimiliano
 Distribuzione geografica
Continente #
NA - Nord America 10.400
EU - Europa 7.540
AS - Asia 6.850
SA - Sud America 1.511
Continente sconosciuto - Info sul continente non disponibili 321
AF - Africa 209
OC - Oceania 26
Totale 26.857
Nazione #
US - Stati Uniti d'America 10.120
SG - Singapore 3.213
DE - Germania 2.712
CN - Cina 1.543
BR - Brasile 1.224
SE - Svezia 1.193
IT - Italia 921
VN - Vietnam 609
FR - Francia 554
UA - Ucraina 456
IE - Irlanda 337
FI - Finlandia 314
GB - Regno Unito 312
IN - India 261
ID - Indonesia 228
PL - Polonia 216
JP - Giappone 172
RU - Federazione Russa 159
HK - Hong Kong 157
BD - Bangladesh 139
CA - Canada 118
AR - Argentina 100
IQ - Iraq 95
TR - Turchia 87
NL - Olanda 66
MX - Messico 63
AT - Austria 58
ZA - Sudafrica 55
KR - Corea 53
CI - Costa d'Avorio 49
BE - Belgio 45
EC - Ecuador 44
ES - Italia 43
PK - Pakistan 36
CO - Colombia 35
VE - Venezuela 35
IR - Iran 30
SA - Arabia Saudita 30
UZ - Uzbekistan 24
CL - Cile 22
MA - Marocco 22
JO - Giordania 21
JM - Giamaica 19
PY - Paraguay 19
AU - Australia 18
CH - Svizzera 18
TN - Tunisia 16
AE - Emirati Arabi Uniti 15
AZ - Azerbaigian 15
KE - Kenya 15
RO - Romania 15
CZ - Repubblica Ceca 14
DO - Repubblica Dominicana 14
PE - Perù 13
DZ - Algeria 12
LT - Lituania 12
PT - Portogallo 12
CR - Costa Rica 11
KZ - Kazakistan 11
MY - Malesia 11
UY - Uruguay 11
EG - Egitto 10
IL - Israele 10
PA - Panama 10
PH - Filippine 10
A2 - ???statistics.table.value.countryCode.A2??? 8
BO - Bolivia 8
GR - Grecia 8
NI - Nicaragua 8
NP - Nepal 8
PS - Palestinian Territory 8
TT - Trinidad e Tobago 8
DK - Danimarca 7
HU - Ungheria 7
MD - Moldavia 7
NZ - Nuova Zelanda 7
TH - Thailandia 7
AM - Armenia 6
KG - Kirghizistan 6
NO - Norvegia 6
OM - Oman 6
SK - Slovacchia (Repubblica Slovacca) 6
SN - Senegal 6
AL - Albania 5
BG - Bulgaria 5
BH - Bahrain 5
EE - Estonia 5
HN - Honduras 5
HR - Croazia 5
LB - Libano 5
LV - Lettonia 5
MN - Mongolia 5
AO - Angola 4
BY - Bielorussia 4
ET - Etiopia 4
GT - Guatemala 4
KH - Cambogia 4
RS - Serbia 4
BN - Brunei Darussalam 3
BS - Bahamas 3
Totale 26.484
Città #
Singapore 1.704
Chandler 1.160
Ashburn 1.151
San Jose 1.037
Frankfurt am Main 408
Munich 374
Dublin 333
Beijing 324
Jacksonville 294
San Mateo 264
New York 241
Jakarta 209
Ho Chi Minh City 208
Lauterbourg 202
Los Angeles 196
Warsaw 190
Rome 174
Wilmington 173
Hefei 168
Ann Arbor 161
Helsinki 161
Nanjing 156
Nürnberg 150
Tokyo 150
Hanoi 145
Hong Kong 145
Boston 138
Houston 129
São Paulo 118
Dallas 110
Chicago 109
Milan 104
Redmond 104
Woodbridge 101
Princeton 96
Dearborn 95
Moscow 90
Atlanta 79
Santa Clara 78
Buffalo 76
Lawrence 72
Seattle 67
Cattolica 66
Fairfield 65
Nanchang 63
Redwood City 60
Marseille 55
Bremen 52
Nuremberg 50
Abidjan 49
Kent 48
Rio de Janeiro 47
Brooklyn 46
Seoul 46
Norwalk 45
London 38
The Dalles 38
Baghdad 37
Brussels 37
Detroit 37
Paris 37
Boardman 36
Hebei 35
Izmir 35
Council Bluffs 34
Johannesburg 34
Orem 34
Phoenix 34
Belo Horizonte 32
North Bergen 32
Shanghai 32
Tukwila 32
Mountain View 30
Vienna 30
Guangzhou 29
University Park 29
Pune 28
Düsseldorf 27
Tianjin 27
Kunming 26
Lappeenranta 26
Toronto 26
Chennai 25
Haiphong 25
Leawood 25
Da Nang 23
Shenyang 23
Washington 23
Dhaka 22
Salt Lake City 22
Turku 22
Denver 21
Montreal 21
St Louis 21
Tashkent 21
Amman 20
Jiaxing 20
Stockholm 20
Brasília 19
Changsha 19
Totale 13.400
Nome #
MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle. 421
Mutations in the 3' untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis 321
The Expanding Role of the Infectious Disease Expert in the Context of the MS Centre 307
The Impact of Neurogenic Lower Urinary Tract Symptoms and Erectile Dysfunctions on Marital Relationship in Men with Multiple Sclerosis: A Single Cohort Study 300
The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review 300
Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort 291
Upper body involvement in GNE myopathy assessed by muscle imaging 269
Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis 266
Hospital admissions from the emergency department of adult patients affected by myopathies 261
Optical Coherence Tomography Advanced Parameters in Patients With Multiple Sclerosis: Ophthalmological and Neurological Assessments 254
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 254
Primary fibroblasts cultures reveal TDP-43 abnormalities in amyotrophic lateral sclerosis patients with and without SOD1 mutations 253
Effects of rehabilitation treatment of the upper limb in Multiple Sclerosis patients and predictive value of neurophysiological measures 251
Novel missense variants associated with GNE myopathy 247
CD8(+) T Cells in Facioscapulohumeral Muscular Dystrophy Patients with Inflammatory Features at Muscle MRI 247
Multiple Sclerosis Onset before and after COVID-19 Vaccination: Can HLA Haplotype Be Determinant? 241
Induction Versus Escalation in Multiple Sclerosis: A 10-Year Real World Study 241
T-bet, pSTAT1 and pSTAT3 expression in peripheral blood mononuclear cells during pregnancy correlates with post-partum activation of multiple sclerosis. 239
alpha-Dystroglycan does not play a major pathogenic role in autosomal recessive hereditary inclusion-body myopathy 201
Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies 198
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes 195
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis. 194
Muscle imaging findings in GNE myopathy 192
Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 189
Cerebellar degeneration associated with mGluR1 autoantibodies as a paraneoplastic manifestation of prostate adenocarcinoma 188
Low reliability of anti-KIR4.183-120 peptide auto-antibodies in multiple sclerosis patients 188
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 181
Mesoangioblasts from Facioscapulohumeral Muscular Dystrophy display in vivo a variable myogenic ability predictable by their in vitro behavior. 179
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 177
Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients. 175
Sleep Disordered Breathing in a cohort of patients with sporadic Inclusion Body Myositis. 174
A human anti-Neuronal Autoantibody Against GABAB Receptor induces Experimental Autoimmune Agrypnia 173
Hereditary inclusion-body myopathy with sparing of the quadriceps: the many tiles of an incomplete puzzle 171
Muscle MRI in female carriers of dystrophinopathy 168
A Case of Hemiabdominal Myoclonus 168
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 167
Serum-Circulating microRNAs in Sporadic Inclusion Body Myositis 166
An Italian family with inclusion-body myopathy and frontotemporal dementia due to mutation in the VCP gene 163
Intravascular large B-cell lymphoma presenting as slowly progressive paraparesis with normal MRI features 161
New onset of Susac syndrome after mRNA COVID-19 vaccine: a case report 159
Idiopathic inflammatory myopathies evaluated by near infrared spectroscopy 158
TWEAK in inclusion-body myositis muscle: possible pathogenic role of a cytokine inhibiting myogenesis 157
Progressive multifocal leukoencephalopathy in a patient with Franklin disease and hypogammaglobulinemia. 155
Low reliability of anti-KIR4.183–120peptide auto-antibodies in multiple sclerosis patients 155
Hyposialylation of neprilysin possibly affects its expression and enzymatic activity in hereditary inclusion-body myopathy muscle 154
A TLR/CD44 axis regulates T cell trafficking in experimental and human multiple sclerosis 154
Hereditary inclusion-body myopathy: clues on pathogenesis and possible therapy 153
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 151
Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients 151
Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles 150
Wash-out duration and lymphocyte count in switching from fingolimod to ofatumumab: A case report and literature review 150
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 148
IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis. 148
Mutations in the 3' untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis 147
Analysis of NCAM helps identify unusual phenotypes of hereditary inclusion-body myopathy 146
An Italian case of hereditary myopathy with early respiratory failure (HMERF) not associated with the titin kinase domain R279W mutation 145
Depression in multiple sclerosis: effect of brain derived neurotrophic factor Val66Met polymorphism and disease perception 144
The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis. 143
Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis 143
Novel SEC61G-EGFR fusion gene in pediatric ependymomas discovered by clonal expansion of stem cells in absence of exogenous mitogens 141
Long-term Follow-up and Muscle Imaging Findings in Brachio-Cervical Inflammatory Myopathy 141
Acyclovir-related kidney injury during alemtuzumab infusion 138
Sleep and fatigue in multiple sclerosis: A questionnaire-based, cross-sectional, cohort study 138
Neprilysin participates in skeletal muscle regeneration and is accumulated in abnormal muscle fibres of inclusion body myositis. 135
Severe disability in patients with relapsing-remitting multiple sclerosis is associated with profound changes in the regulation of leptin secretion 135
A Case of Hemiabdominal Myoclonus 134
Sleep disorder associated with antibodies to IgLON5: parasomnia or agrypnia? 134
Relapsing-remitting autoimmune agrypnia 129
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 127
Defining the disease course of TNFα blockers-associated Multiple Sclerosis 127
Muscle involvement in myasthenia gravis: Expanding the clinical spectrum of myasthenia-myositis association from a large cohort of patients 126
Dominus effect: challenging complications of alemtuzumab-related thyroid autoimmunity 126
ANCA-related vasculitic neuropathy mimicking motor neuron disease. 125
Increased aging in primary muscle cultures of sporadic inclusion-body myositis. 125
Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis. 125
Coeliac disease presenting with acute disseminated encephalomyelitis. 124
Neurotriphic factor in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapy 124
Cerebellar degeneration and ocular myasthenia gravis in a patient with recurring ovarian carcinoma. 124
Bilateral thoracic long nerve involvement in motor multifocal neuropathy 123
Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients 122
CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis 122
Case of postpartum Parsonage-Turner syndrome 122
Lower urinary tract disorders in multiple sclerosis patients: prevalence, clinical features, and response to treatments 122
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 121
Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients 120
Oculopharyngeal muscular dystrophy: Clinical and neurophysiological features 120
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 120
Coeliac disease presenting with acute disseminated encephalomyelitis 119
Mesoangioblasts of inclusion-body myositis: a twofold tool to study pathogenic mechanisms and enhance defective muscle regeneration 119
An Italian family with autosomal recessive inclusion-body myopathy and mutations in the GNE gene 119
Lower motor neuron involvement in longitudinally extensive transverse myelitis with and without aquaporin-4 antibodies 119
Severe dyspnoea with alteration of the diffusion capacity of the lung associated with fingolimod treatment 119
Regulatory T cells fail to suppress CD4(+)T-bet(+) T cells in relapsing multiple sclerosis patients 118
Leptin enhances the release of cytokines by peripheral blood mononuclear cells from relapsing multiple sclerosis patients 118
Vessel-associated stem cells from skeletal muscle: From biology to future uses in cell therapy 117
BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression 117
A unique case of multiphasic ADEM or what else? 117
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 117
Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study 117
Pilot trial of simvastatin in the treatment of sporadic inclusion-body myositis 115
Totale 16.843
Categoria #
all - tutte 112.884
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.884


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.471 0 100 33 197 50 59 45 244 96 84 245 318
2022/20233.220 381 429 265 463 225 428 148 274 386 49 121 51
2023/20241.639 61 465 60 119 53 223 115 68 24 57 179 215
2024/20253.881 79 98 306 144 204 205 246 242 626 290 818 623
2025/20269.709 1.404 282 609 1.036 1.658 762 1.597 481 633 617 362 268
2026/20271.659 428 1.231 0 0 0 0 0 0 0 0 0 0
Totale 26.857